COX-3: in the wrong frame in mind
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A full-length, catalytically active form of COX-3 does not exist in humans.
“However, further genomic and kinetic studies showed that a full-length, catalytically active form of COX-3 does not exist in humans35,36”
Cites
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,692 · see citing works
Anti-Inflammatory Action and Mechanisms of Resveratrol
Meng, T., Xiao, D., Muhammed, A., Deng, J., Chen, L., & He, J. (2021) · Molecules · doi:10.3390/molecules26010229 · Cited by 730 · see citing works
Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications
Alarcón‐de‐la‐Lastra, C., & Villegas, I. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500022 · Cited by 705 · see citing works
Mechanism of Action of Paracetamol
Graham, G. G., & Scott, K. F. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00008 · Cited by 648 · see citing works
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
Warner, T. D., & Mitchell, J. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0645rev · Cited by 613 · see citing works
Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man
Hinz, B., Cheremina, O., & Brune, K. (2008) · The FASEB Journal · doi:10.1096/fj.07-8506com · Cited by 478 · see citing works
Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships.
Zarghi, A., & Arfaei, S. (2011) · Europe PMC (PubMed Central) · Cited by 402 · see citing works
Fever and hypothermia in systemic inflammation: recent discoveries and revisions
Romanovsky, A. A. (2005) · Frontiers in bioscience · doi:10.2741/1690 · Cited by 344 · see citing works
Renal adverse effects of nonsteroidal anti-inflammatory drugs
Harirforoosh, S., & Jamali, F. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903311023 · Cited by 260 · see citing works
Burian, M., & Geißlinger, G. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.02.004 · Cited by 259 · see citing works
Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties
Kis, B., Snipes, J. A., & Busija, D. W. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085431 · Cited by 250 · see citing works
ARONOFF, D., OATES, J., & BOUTAUD, O. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.09.009 · Cited by 222 · see citing works
Cyclooxygenase-2 and its role in ovulation: a 2004 account
Sirois, J., Sayasith, K., Brown, K. A., Stock, A. E., Bouchard, N., & Doré, M. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh032 · Cited by 212 · see citing works
Inhibitors of cyclooxygenases: mechanisms, selectivity and uses.
Botting, R. M. (2006) · PubMed · Cited by 199 · see citing works
Townsend, K. P., & Praticò, D. (2005) · The FASEB Journal · doi:10.1096/fj.04-3620rev · Cited by 196 · see citing works
Paracetamol – An old drug with new mechanisms of action
Przybyła, G. W., Szychowski, K. A., & Gmiński, J. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13392 · Cited by 190 · see citing works
Cyclooxygenases in the skin: pharmacological and toxicological implications
Lee, J. L., Mukhtar, H., Bickers, D. R., Kopelovich, L., & Athar, M. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00301-6 · Cited by 189 · see citing works
Hinz, B., Cheremina, O., Bachmakov, J., Renner, B., Zolk, O., Fromm, M. F., & Brune, K. (2007) · The FASEB Journal · doi:10.1096/fj.06-8061com · Cited by 149 · see citing works
Analysis of Cyclooxygenase 2 (COX-2) Expression During Malignant Melanoma Progression
Goulet, A.-C., Einsphar, J., & Alberts, D. S. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.6.627 · Cited by 141 · see citing works
Cellular mechanisms of acetaminophen: role of cyclo‐oxygenase
Lucas, R., Warner, T. D., Vojnovic, I., & Mitchell, J. A. (2005) · The FASEB Journal · doi:10.1096/fj.04-2437fje · Cited by 128 · see citing works
New insights into COX-2 biology and inhibition
Patrignani, P., Tacconelli, S., Sciulli, M. G., & Capone, M. L. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.024 · Cited by 128 · see citing works
Targeting signal transduction pathways by chemopreventive agents
Bode, A. M., & Dong, Z. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.05.018 · Cited by 126 · see citing works
Ulrich, C. M., Whitton, J. A., Yu, J., Sibert, J. G., Sparks, R., Potter, J. D., & Bigler, J. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0510 · Cited by 114 · see citing works
Cyclooxygenase-3: axiom, dogma, anomaly, enigma or splice error?--Not as easy as 1, 2, 3.
Davies, N. M., Good, R. L., Roupe, K., & Yáñez, J. A. (2004) · PubMed · Cited by 95 · see citing works
In Vitro Effects on Polydextrose by Colonic Bacteria and Caco-2 Cell Cyclooxygenase Gene Expression
Mäkivuokko, H., Nurmi, J., Nurminen, P. H., Stowell, J. D., & Rautonen, N. (2005) · Nutrition and Cancer · doi:10.1207/s15327914nc5201_12 · Cited by 93 · see citing works
Cyclooxygenase: Past, present and future. A tribute to John R. Vane (1927–2004)
Botting, R. M. (2006) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2005.11.008 · Cited by 92 · see citing works
Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?
Hersh, E. V., Lally, E. T., & Moore, P. A. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x56367 · Cited by 89 · see citing works
COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells
Shaftel, S. S., Olschowka, J. A., Hurley, S. D., Moore, A. H., & O’Banion, M. K. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.09.006 · Cited by 89 · see citing works
Mechanism of the Antinociceptive Effect of Paracetamol*
Bonnefont, J., Courade, J., Alloui, A., & Eschalier, A. (2003) · Drugs · doi:10.2165/00003495-200363992-00002 · Cited by 86 · see citing works
Prostaglandin and the Suppression of Phagocyte Innate Immune Responses in Different Organs
de Medeiros, A. I., Peres‐Buzalaf, C., Verdan, F. F., & Serezani, C. H. (2012) · Mediators of Inflammation · doi:10.1155/2012/327568 · Cited by 86 · see citing works
Cloning and Characterization of Cyclooxygenase-1b (Putative Cyclooxygenase-3) in Rat
Snipes, J. A., Kis, B., Shelness, G. S., Hewett, J. A., & Busija, D. W. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079533 · Cited by 82 · see citing works
Mallet, C., Desmeules, J., Pegahi, R., & Eschalier, A. (2023) · Journal of Pain Research · doi:10.2147/jpr.s393809 · Cited by 83 · see citing works
Ayoub, S. S., Colville-Nash, P. R., Willoughby, D. A., & Botting, R. M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.061 · Cited by 79 · see citing works
Qin, N., Zhang, S.-P., Reitz, T. L., Mei, J. M., & Flores, C. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090944 · Cited by 77 · see citing works
From NSAIDs to Glucocorticoids and Beyond
Sinniah, A., Yazid, S., & Flower, R. (2021) · Cells · doi:10.3390/cells10123524 · Cited by 80 · see citing works
The Molecular Toxicology of Acetaminophen
Josephy, P. D. (2005) · Drug Metabolism Reviews · doi:10.1080/03602530500205200 · Cited by 74 · see citing works
Cyclooxygenase-2 Inhibitors: A Painful Lesson
Sanghi, S., MacLaughlin, E. J., Jewell, C. W., Chaffer, S., Naus, P., Watson, L. E., & Dostal, D. E. (2006) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/187152906777441803 · Cited by 73 · see citing works
Kapoor, M., Kojima, F., Yang, L., & Crofford, L. J. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.11.006 · Cited by 66 · see citing works
Cyclooxygenase-3 Gene Expression in Alzheimer Hippocampus and in Stressed Human Neural Cells
Cui, J.-G., Kuroda, H., Chandrasekharan, N. V., Peláez, R. P., Simmons, D. L., Bazan, N. G., & Lukiw, W. J. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000035809.70905.8a · Cited by 65 · see citing works
Schwab, J. M., Schluesener, H. J., Meyermann, R., & Serhan, C. N. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.07.003 · Cited by 65 · see citing works
Signal Transduction Pathways in Cancer Development and as Targets for Cancer Prevention
Bode, A. M., & Dong, Z. (2005) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(04)79005-4 · Cited by 64 · see citing works
Weinheimer-Haus, E. M., Jemioło, B., Carroll, C. C., Harber, M. P., Haus, J. M., Burd, N. A., LeMoine, J. K., Trappe, S. W., & Trappe, T. A. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00718.2006 · Cited by 60 · see citing works
Pain and osteoarthritis: new drugs and mechanisms
Hinz, B., & Brune, K. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.hco.0000136130.95746.14 · Cited by 58 · see citing works
The Role of Resveratrol in Eye Diseases—A Review of the Literature
Bryl, A., Falkowski, M., Zorena, K., & Mrugacz, M. (2022) · Nutrients · doi:10.3390/nu14142974 · Cited by 49 · see citing works
Hinz, B., & Brune, K. (2007) · Springer eBooks · doi:10.1007/978-3-540-33823-9_3 · Cited by 49 · see citing works
Warner, T. D., Vojnovic, I., Giuliano, F., Jiménez, R., Bishop‐Bailey, D., & Mitchell, J. A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063875 · Cited by 48 · see citing works
Pisoschi, A. M., Iordache, F., Stanca, L., Cimpeanu, C. L., Furnaris, F., Geicu, O. I., Bîlteanu, L., & Șerban, A. I. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116075 · Cited by 48 · see citing works
Regional distribution of cyclooxygenase-3 mRNA in the rat central nervous system
Kis, B., Snipes, J. A., Bari, F., & Busija, D. W. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.03.015 · Cited by 43 · see citing works
Expanding the febrigenic role of cyclooxygenase-2 to the previously overlooked responses
Steiner, A. A., Rudaya, A. Y., Robbins, J. R., Dragic, A. S., Langenbach, R., & Romanovsky, A. A. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00371.2005 · Cited by 42 · see citing works
Bonnefont, J., Daulhac, L., Etienne, M., Chapuy, E., Mallet, C., Ouchchane, L., Deval, C., Courade, J.-P., Ferrara, M., Eschalier, A., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.025775 · Cited by 39 · see citing works
Cyclooxygenase variants: The role of alternative splicing
Roos, K., & Simmons, D. L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.031 · Cited by 35 · see citing works
Bitterness Evaluation of Acidic Pharmaceutical Substances (NSAIDs) Using a Taste Sensor
Yoshida, M., Haraguchi, T., & Uchida, T. (2014) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c14-00577 · Cited by 30 · see citing works
Sciulli, M. G., Capone, M. L., Tacconelli, S., & Patrignani, P. (2005) · PubMed · Cited by 30 · see citing works
Berenbaum, F. (2004) · Joint Bone Spine · doi:10.1016/j.jbspin.2004.02.003 · Cited by 30 · see citing works
Schneider, C. G., Boeglin, W. E., & BRASH, A. R. (2004) · Biochemical Journal · doi:10.1042/bj20041115 · Cited by 27 · see citing works
Munsterhjelm, E., Niemi, T., Ylikorkala, O., Silvanto, M., & Rosenberg, P. H. (2005) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2005.00707.x · Cited by 27 · see citing works
Basselin, M., Villacreses, N. E., Langenbach, R. I., Ma, K., Bell, J. M., & Rapoport, S. I. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03612.x · Cited by 27 · see citing works
New insights into eicosanoid biosynthetic pathways: implications for arthritis
Kojima, F., Kapoor, M., Kawai, S., & Crofford, L. J. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.2.277 · Cited by 25 · see citing works
Tiippana, E., Hamunen, K., Kontinen, V., & Kalso, E. A. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2012.00935.x · Cited by 24 · see citing works
Nonsteroidal Anti-inflammatory Drugs, Acetaminophen, and COX-2 Inhibitors
Birmingham, B., & Buvanendran, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-323-08340-9.00040-2 · Cited by 24 · see citing works
Girolamo, G. D., Sánchez, A. J., Santos, A. R. D. L., & González, C. D. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.3.561 · Cited by 23 · see citing works
Anti-Inflammatory Properties of Resveratrol
Wątroba, M., & Szukiewicz, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311710 · Cited by 22 · see citing works
Nurmi, J. T., Puolakkainen, P. A., & Rautonen, N. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.07.004 · Cited by 22 · see citing works
Libert, F., Bonnefont, J., Bourinet, E., Doucet, E., Alloui, A., Hamon, M., Nargeot, J., & Eschalier, A. (2004) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)05657-8 · Cited by 22 · see citing works
COX-3: Uncertainties and controversies
Kam, P. C. A., & So, A. (2008) · Current Anaesthesia and Critical Care · doi:10.1016/j.cacc.2008.11.003 · Cited by 20 · see citing works
Ayoub, S. S., & Flower, R. J. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172609 · Cited by 19 · see citing works
Ayoub, S. S., Wood, E. G., Hassan, S.-U., & Bolton, C. (2011) · Inflammation Research · doi:10.1007/s00011-011-0352-3 · Cited by 19 · see citing works
Moreira, V., Gutiérrez, J. M., Amaral, R. B., Lomonte, B., Purgatto, E., & Teixeira, C. (2010) · Toxicon · doi:10.1016/j.toxicon.2010.12.004 · Cited by 19 · see citing works
Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats
Wood, R. C., Wyatt, J. E., Bullins, K. W., Hanley, A. V., Hanley, G. A., Denham, J. W., Panus, P. C., & Harirforoosh, S. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.035 · Cited by 19 · see citing works
Acetaminophen (Paracetamol) Induces Hypothermia During Acute Cold Stress
Foster, J., Mauger, A. R., Govus, A., Hewson, D., & Taylor, L. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0560-x · Cited by 13 · see citing works
Antipyretic analgesics: basic aspects
Brune, K., & Zeilhofer, H. U. (2006) · Elsevier eBooks · doi:10.1016/b0-443-07287-6/50034-5 · Cited by 13 · see citing works
Antipyretic analgesics: basic aspects
Zeilhofer, H. U., & Brune, K. (2006) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-10278 · Cited by 12 · see citing works
Omar, T. N.-A. (2017) · Iraqi Journal of Pharmaceutical Sciences · doi:10.31351/vol22iss1pp120-127 · Cited by 11 · see citing works
Human cyclooxygenase-1b is not the elusive target of acetaminophen
Censarek, P., Freidel, K., Hohlfeld, T., Schrör, K., & Weber, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.079 · Cited by 10 · see citing works
Nonsteroidal Anti-inflammatory Drugs
Ballou, L. R., & Wang, B. W. E. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3285-4.10054-3 · Cited by 7 · see citing works
Evidence of COX-1 and COX-2 expression in Kaposi’s sarcoma tissues
Rossiello, L., Ruocco, E., Signoriello, G., Micheli, P., Rienzo, M., Claudio Napoli, A., & Rossiello, R. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.03.016 · Cited by 7 · see citing works
Neurodegeneration from Drugs and Aging‐Derived Free Radicals
Ramkissoon, A., Shapiro, A. M., Loniewska, M. M., & Wells, P. G. (2013) · doi:10.1002/9781118355886.ch10 · Cited by 6 · see citing works
Le paracétamol : un ancêtre plein d’avenir
Mallet, C., Barrière, D. A., & Eschalier, A. (2012) · Therapies · doi:10.2515/therapie/2012039 · Cited by 5 · see citing works
Part I. Mechanisms of actions and metabolism of acetaminophen related to the neonatal brain
Angelis, D., Savani, R. C., Jagarapu, J., Hu, J., Wan-Huen, P., & Chalak, L. F. (2021) · Early Human Development · doi:10.1016/j.earlhumdev.2021.105406 · Cited by 6 · see citing works
MOLECULAR DOCKING STUDY OF THE AFFINITY OF CYP2C9 AND CYP2D6 FOR IMRECOXIB
Yao, Y., Han, W., Zhou, Y., Li, Z., Li, Q., & Zhong, D. (2007) · Journal of Theoretical and Computational Chemistry · doi:10.1142/s0219633607003179 · Cited by 5 · see citing works
Flores, C. M., Carson, J. R., Codd, E. E., Dax, S. L., Kuffner, E. K., Stahle, P. L., Neff, R. A., & Eichenbaum, G. E. (2025) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2025.105830 · Cited by 3 · see citing works
Zakharova, I. N., Berezhnaya, I. V., Pupykina, V. V., Gostyukhina, A. D., & Dubovets, N. F. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-367 · Cited by 3 · see citing works
Robert, C., Saenz‐Feijoo, R., Gaudy, J., & Arreto, C. (2009) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00655.x · Cited by 3 · see citing works
Mahdi, M. F. (2017) · Iraqi Journal of Pharmaceutical Sciences · doi:10.31351/vol17iss1pp7-15 · Cited by 3 · see citing works
Schmerztherapie mit antipyretischen Analgetika
Hinz, B., & Brune, K. (2006) · Der Orthopäde · doi:10.1007/s00132-006-1024-9 · Cited by 3 · see citing works
Nonsteroidal Anti-Inflammatory Drugs
Flower, R. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195737.020 · Cited by 2 · see citing works
Actualización en la Farmacología de los AINES (Anti-Inflamatorios No Esteroideos)
Regueras, E., Velázquez, I., & Torres, L. M. (2024) · Multidisciplinary Pain Journal · doi:10.20986/mpj.2024.1059/2023 · Cited by 2 · see citing works
Berenbaum, F. (2004) · Revue du Rhumatisme · doi:10.1016/j.rhum.2004.02.004 · Cited by 1 · see citing works
The molecular and biological basis for COX-2 selectivity
Trummlitz, G., van Ryn, J., & Warner, T. D. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7879-1_3 · Cited by 1 · see citing works
Regulation of cyclooxygenase gene expression by glucocorticoids in cardiomyocytes
Sun, H. (2007) · UA Campus Repository (The University of Arizona)
Development of Cyclooxygenases in the Treatment of Pain, Fever and Inflammation.
Asif, M. (2014) · Research and reviews : journal of pharmaceutics and nanotechnology
Ramkissoon, A. (2012) · TSpace (University of Toronto)
Chemopräventive Effekte von n-3 mehrfach ungesättigten Fettsäuren und Fisch in humanen Kolonzellen
Haber, J. E. (2010) · Common Library Network (Der Gemeinsame Bibliotheksverbund)
Nonsteroidal Anti-inflammatory Drugs, Acetaminophen, and COX-2 Inhibitors
Buvanendran, A., & Reuben, S. S. (2008) · Elsevier eBooks · doi:10.1016/b978-032304184-3.50038-8
Kotob, F., & Lema, M. J. (2006) · Elsevier eBooks · doi:10.1016/b978-0-7216-0261-5.50026-0
Brune, K., & Zeilhofer, H. U. (2007) · Elsevier eBooks · doi:10.1016/b978-84-8174-949-6.50029-0
- Authors
- Dinchuk, J. E., Liu, R. Q., & Trzaskos, J. M.
- Affiliations
- Bristol-Myers Squibb (United States) (US)
- Corresponding author
- Dinchuk, Joseph E.
- Venue
- Immunology Letters
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 86
- Issue
- 1
- Pages
- 121
- ISSN
- 0165-2478 (ISSN-L)
- OpenAlex
- W2051708832
- Cited by
- 100
- References
- 1
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 1 · 2017: 3 · 2014: 2 · 2013: 3 · 2012: 4
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Immunology Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- COX-3, cyclooxygenase, prostaglandin synthesis
- MeSH terms
- Animals, Cerebral Cortex, Cloning, Molecular, Humans, Introns, Isoenzymes, Membrane Proteins, Prostaglandin-Endoperoxide Synthases, Sequence Homology, Nucleic Acid, Sequence Analysis, DNA, DNA, Complementary, Cyclooxygenase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review